Literature DB >> 9229281

Measuring symptomatic and functional recovery in patients with community-acquired pneumonia.

J P Metlay1, M J Fine, R Schulz, T J Marrie, C M Coley, W N Kapoor, D E Singer.   

Abstract

OBJECTIVE: To determine the rates of resolution of symptoms and return to premorbid health status and assess the association of these outcomes with health care utilization in patients with community-acquired pneumonia.
DESIGN: A prospective, multicenter cohort study.
SETTING: Inpatient and outpatient facilities at three university hospitals, one community hospital, and one staff-model health maintenance organization. PATIENTS: Five hundred seventy-six adults (aged > or = 18 years) with clinical and radiographic evidence of pneumonia, judged by a validated pneumonia severity index to be at low risk of dying.
MEASUREMENTS AND MAIN RESULTS: The presence and severity of five symptoms (cough, fatigue, dyspnea, sputum, and chest pain) were recorded through questionnaires administered at four time points: 0, 7, 30, and 90 days from the time of radiographic diagnosis of pneumonia. A summary symptom score was tabulated as the sum of the five individual severity scores. Patients also provided responses to the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) and reported the number of and reason for outpatient physician visits. Symptoms and health status 30 days before pneumonia onset (prepneumonia) were obtained at the initial interview. All symptoms, except pleuritic chest pain, were still commonly reported at 30 days, and the prevalence of each symptom at 90 days was still nearly twice prepneumonia levels. Physical health measures derived from the SF-36 Form declined significantly at presentation but continued to improve over all three follow-up time periods. Patients with elevated symptom scores at day 7 or day 30 were significantly more likely to report pneumonia-related ambulatory care visits at the subsequent day 30 or day 90 interviews, respectively.
CONCLUSIONS: Disease-specific symptom resolution and recovery of the premorbid physical health status requires more than 30 days for many patients with pneumonia. Delayed resolution of symptoms is associated with increased utilization of outpatient physician visits.

Entities:  

Mesh:

Year:  1997        PMID: 9229281      PMCID: PMC1497132          DOI: 10.1046/j.1525-1497.1997.00074.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  20 in total

1.  Failure of resolution in pneumonia.

Authors:  D H Boyd
Journal:  Br J Dis Chest       Date:  1975-10

2.  Prognosis of patients hospitalized with community-acquired pneumonia.

Authors:  M J Fine; J J Orloff; D Arisumi; G D Fang; V C Arena; B H Hanusa; V L Yu; D E Singer; W N Kapoor
Journal:  Am J Med       Date:  1990-05       Impact factor: 4.965

3.  Pneumonia in New Guinea. I. Bacteriological findings in 632 adults with particular reference to haemophilus influenzae.

Authors:  R M Douglas; L Devitt
Journal:  Med J Aust       Date:  1973-01-13       Impact factor: 7.738

4.  Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service.

Authors: 
Journal:  Q J Med       Date:  1987-03

5.  Comparison of a disease-specific and a generic severity of illness measure for patients with community-acquired pneumonia.

Authors:  M J Fine; B H Hanusa; J R Lave; D E Singer; R A Stone; L A Weissfeld; C M Coley; T J Marrie; W N Kapoor
Journal:  J Gen Intern Med       Date:  1995-07       Impact factor: 5.128

Review 6.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

7.  Community-acquired pneumonia requiring hospitalization: 5-year prospective study.

Authors:  T J Marrie; H Durant; L Yates
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

8.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Authors:  N R Anthonisen; J Manfreda; C P Warren; E S Hershfield; G K Harding; N A Nelson
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

9.  Effect sizes for interpreting changes in health status.

Authors:  L E Kazis; J J Anderson; R F Meenan
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

10.  Comparison of self-reported fatigue in rheumatoid arthritis and controls.

Authors:  B L Belza
Journal:  J Rheumatol       Date:  1995-04       Impact factor: 4.666

View more
  34 in total

1.  Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia.

Authors:  J A Brandenburg; T J Marrie; C M Coley; D E Singer; D S Obrosky; W N Kapoor; M J Fine
Journal:  J Gen Intern Med       Date:  2000-09       Impact factor: 5.128

2.  Development and validation of a short questionnaire in community acquired pneumonia.

Authors:  R El Moussaoui; B C Opmeer; P M M Bossuyt; P Speelman; C A J M de Borgie; J M Prins
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

3.  Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.

Authors:  M M van der Eerden; F Vlaspolder; C S de Graaff; T Groot; W Bronsveld; H M Jansen; W G Boersma
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

4.  Improving the quality of pneumonia care that patients experience.

Authors:  Carol R Horowitz; Mark R Chassin
Journal:  Am J Med       Date:  2002-10-01       Impact factor: 4.965

5.  Healthcare reconsultation in working-age adults following hospitalisation for community-acquired pneumonia.

Authors:  Priya Daniel; Thomas Bewick; Tricia M McKeever; Mark Roberts; Deborah Ashton; Daniel Smith; Lenny Latip; Wei Shen Lim
Journal:  Clin Med (Lond)       Date:  2018-02       Impact factor: 2.659

6.  Community-acquired pneumonia: symptoms and burden of illness at diagnosis among US adults aged 50 years and older.

Authors:  Kathleen W Wyrwich; Holly Yu; Reiko Sato; David Strutton; John H Powers
Journal:  Patient       Date:  2013       Impact factor: 3.883

7.  Fatigue in patients with erythema migrans.

Authors:  Gary P Wormser; Praveen Sudhindra; Eliana Lopez; Lisa Patel; Sara Rezai; Aaron D Brumbaugh; Donna McKenna; Carol Scavarda; Eugene D Shapiro; Carol L Karmen; Paul Visintainer
Journal:  Diagn Microbiol Infect Dis       Date:  2016-07-27       Impact factor: 2.803

8.  High-dose oral vitamin D supplementation and mortality in people aged 65-84 years: the VIDAL cluster feasibility RCT of open versus double-blind individual randomisation.

Authors:  Christine Rake; Clare Gilham; Laurette Bukasa; Richard Ostler; Michelle Newton; James Peto Wild; Benoit Aigret; Michael Hill; Oliver Gillie; Irwin Nazareth; Peter Sasieni; Adrian Martineau; Julian Peto
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

9.  Efficacy of osteopathic manipulation as an adjunctive treatment for hospitalized patients with pneumonia: a randomized controlled trial.

Authors:  Donald R Noll; Brian F Degenhardt; Thomas F Morley; Francis X Blais; Kari A Hortos; Kendi Hensel; Jane C Johnson; David J Pasta; Scott T Stoll
Journal:  Osteopath Med Prim Care       Date:  2010-03-19

Review 10.  [Diagnostic procedures for patients with community acquired pneumonia].

Authors:  U Flückiger; M Battegay; G Laifer
Journal:  Internist (Berl)       Date:  2007-05       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.